These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12660937)

  • 1. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.
    Albert MJ; Qadri F; Wahed MA; Ahmed T; Rahman AS; Ahmed F; Bhuiyan NA; Zaman K; Baqui AH; Clemens JD; Black RE
    J Infect Dis; 2003 Mar; 187(6):909-13. PubMed ID: 12660937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
    Ahmed T; Arifuzzaman M; Lebens M; Qadri F; Lundgren A
    Vaccine; 2009 Dec; 28(2):422-9. PubMed ID: 19837094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding.
    Ahmed T; Svennerholm AM; Al Tarique A; Sultana GN; Qadri F
    Vaccine; 2009 Feb; 27(9):1433-9. PubMed ID: 19146904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR.
    Cooper PJ; Chico ME; Losonsky G; Sandoval C; Espinel I; Sridhara R; Aguilar M; Guevara A; Guderian RH; Levine MM; Griffin GE; Nutman TB
    J Infect Dis; 2000 Oct; 182(4):1199-206. PubMed ID: 10979918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine.
    Qadri F; Ahmed T; Wahed MA; Ahmed F; Bhuiyan NA; Rahman AS; Clemens JD; Black RE; Albert MJ
    Vaccine; 2004 Jan; 22(3-4):416-21. PubMed ID: 14670323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
    Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
    Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
    Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
    Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
    Taylor DN; Cárdenas V; Perez J; Puga R; Svennerholm AM
    Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.
    Lagos R; Fasano A; Wasserman SS; Prado V; San Martin O; Abrego P; Losonsky GA; Alegria S; Levine MM
    J Infect Dis; 1999 Nov; 180(5):1709-12. PubMed ID: 10515838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.
    Kanungo S; Lopez AL; Ali M; Manna B; Kim DR; Mahapatra T; Holmgren J; Dhingra MS; Weirzba TF; Nair GB; Bhattacharya SK; Clemens JD; Sur D
    PLoS One; 2014; 9(5):e96499. PubMed ID: 24800828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
    Khan MU; Barua DK; Begum T; Shahidullah M
    Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States.
    McCarty JM; Cassie D; Bedell L; Lock MD; Bennett S
    Am J Trop Med Hyg; 2021 Apr; 104(5):1758-1760. PubMed ID: 33819178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial.
    Deloria-Knoll M; Steinhoff M; Semba RD; Nelson K; Vlahov D; Meinert CL
    Vaccine; 2006 Mar; 24(10):1670-9. PubMed ID: 16256250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
    Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Huda S; Huq MI; Holmgren J
    Pediatr Infect Dis J; 1989 Feb; 8(2):105-9. PubMed ID: 2704600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.
    Yang JS; Kim HJ; Yun CH; Kang SS; Im J; Kim HS; Han SH
    J Microbiol Methods; 2007 Nov; 71(2):141-6. PubMed ID: 17888533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.